Repository logo
 
Publication

Human, food and animal Campylobacter spp. isolated in Portugal: high genetic diversity and antibiotic resistance rates

dc.contributor.authorDuarte, A.
dc.contributor.authorSantos, A.
dc.contributor.authorManageiro, V.
dc.contributor.authorMartins, A.
dc.contributor.authorFraqueza, M.J.
dc.contributor.authorCaniça, Manuela
dc.contributor.authorDomingues, F.
dc.contributor.authorOleastro, M.
dc.date.accessioned2015-02-19T13:21:48Z
dc.date.available2015-02-19T13:21:48Z
dc.date.issued2014-10
dc.description.abstractInfections by Campylobacter jejuni and Campylobacter coli are considered the major cause of bacterial gastroenteritis in humans, with food being the main source of infection. In this study, a total of 196 Campylobacter strains (125 isolates from humans, 39 from retail food and 32 from food animal sources) isolated in Portugal between 2009 and 2012 were characterised by multilocus sequence typing (MLST) and flaA short variable region (SVR) typing. Susceptibility to six antibiotics as well as the mechanisms underlying antibiotic resistance phenotypes was also studied. Based on MLST typing, C. coli strains were genetically more conserved, with a predominant clonal complex (CC828), than C. jejuni strains. In contrast, C. coli isolates were genetically more variable than C. jejuni with regard to flaA-SVR typing. A high rate of resistance was observed for quinolones (100% to nalidixic acid, >90% to ciprofloxacin) and, in general, resistance was more common among C. coli, especially for erythromycin (40.2% vs. 6.7%). In addition, most isolates (86%) were resistant to multiple antimicrobial families. Besides the expected point mutations associated with antibiotic resistance, detected polymorphisms in the cmeABC locus likely play a role in the multiresistant phenotype. This study provides for the first time an overview of the genetic diversity of Campylobacter strains from Portugal. It also shows a worrying antibiotic multiresistance rate and the emergence of Campylobacter strains resistant to antibiotics of human use.por
dc.description.sponsorshipThis work was supported by FEDER funds through Programa Operacional Factores de Competitividade – COMPETE and byNational Funds through FCT (Fundação para a Ciência e Tecnologia)[project PTDC/AGR-ALI/121876/2010].por
dc.identifier.citationInt J Antimicrob Agents. 2014 Oct;44(4):306-13. doi: 10.1016/j.ijantimicag.2014.06.012. Epub 2014 Jul 26por
dc.identifier.doi10.1016/j.ijantimicag.2014.06.012
dc.identifier.issn0924-8579
dc.identifier.urihttp://hdl.handle.net/10400.18/2919
dc.language.isoengpor
dc.peerreviewedyespor
dc.publisherElsevier/ International Society of Chemotherapypor
dc.relationPTDC/AGR-ALI/121876/2010-FCTpor
dc.relation.publisherversionhttp://www.sciencedirect.com/science/article/pii/S0924857914002076por
dc.subjectCampylobacterpor
dc.subjectGenetic Diversitypor
dc.subjectAntibiotic Susceptibilitypor
dc.subjectInfecções Gastrointestinaispor
dc.subjectPortugalpor
dc.titleHuman, food and animal Campylobacter spp. isolated in Portugal: high genetic diversity and antibiotic resistance ratespor
dc.typejournal article
dspace.entity.typePublication
oaire.citation.endPage313por
oaire.citation.startPage306por
oaire.citation.titleInternational Journal of Antimicrobial Agentspor
oaire.citation.volume44(4)por
rcaap.rightsembargoedAccesspor
rcaap.typearticlepor

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
1-s2.0-S0924857914002076-main.pdf
Size:
502.67 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: